UPDATE: Morgan Stanley Reiterates On Amgen, Inc. Following Healthcare Conference

By: via Benzinga
In a report published Thursday, Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating on Amgen, Inc. (NASDAQ: AMGN), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.